THYSSENKRUPP NUCERA AG & CO. KGAA |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.5 EUR | -0.30% |
|
-1.04% | -38.10% |
| 12:21pm | THYSSENKRUPP NUCERA : RBC reaffirms its Buy rating | ZD |
| 05-27 | Bernstein rates Thyssenkrupp Nucera at 'Outperform' | DP |
Valuation
| Fiscal Period: September | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Capitalization 1 | 2,346 | 1,458 | - | - |
| Enterprise Value (EV) 1 | 1,583 | 794.2 | 872.4 | 892.5 |
| P/E ratio | 88.4 x | -47.4 x | 62.3 x | 30.4 x |
| Yield | - | - | - | 0.11% |
| Capitalization / Revenue | 3.59 x | 1.6 x | 1.29 x | 1.07 x |
| EV / Revenue | 2.43 x | 0.87 x | 0.77 x | 0.65 x |
| EV / EBITDA | 55.2 x | -19.2 x | 24.8 x | 11.8 x |
| EV / FCF | -88 x | -6.29 x | -12.2 x | 67 x |
| FCF Yield | -1.14% | -15.9% | -8.19% | 1.49% |
| Price to Book | 3.15 x | 2.03 x | 2.01 x | 1.9 x |
| Nbr of stocks (in thousands) | 126,315 | 126,315 | - | - |
| Reference price 2 | 18.57 | 11.54 | 11.54 | 11.54 |
| Announcement Date | 18/12/23 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: September | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net sales 1 | - | 652.8 | 908.3 | 1,127 | 1,368 |
| EBITDA 1 | - | 28.7 | -41.39 | 35.19 | 75.4 |
| EBIT 1 | - | 23.8 | -45.72 | 18.71 | 57.04 |
| Operating Margin | - | 3.65% | -5.03% | 1.66% | 4.17% |
| Earnings before Tax (EBT) 1 | - | 34.4 | -24.75 | 29.17 | 55.31 |
| Net income 1 | 6.038 | 22.5 | -32.36 | 24.39 | 48.09 |
| Net margin | - | 3.45% | -3.56% | 2.16% | 3.51% |
| EPS 2 | - | 0.2100 | -0.2436 | 0.1852 | 0.3801 |
| Free Cash Flow 1 | - | -18 | -126.2 | -71.42 | 13.32 |
| FCF margin | - | -2.76% | -13.9% | -6.34% | 0.97% |
| FCF Conversion (EBITDA) | - | - | - | - | 17.67% |
| FCF Conversion (Net income) | - | - | - | - | 27.71% |
| Dividend per Share 2 | - | - | - | - | 0.0125 |
| Announcement Date | 23/06/23 | 18/12/23 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: September | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 159.4 | 208.3 | 168 | 376.3 | 241.2 | 248.6 |
| EBITDA 1 | - | - | 0.4 | -9.1 | - | -13.12 | -19.28 |
| EBIT 1 | - | 3.5 | -0.9 | -10.6 | -11.4 | -14.12 | -19.74 |
| Operating Margin | - | 2.2% | -0.43% | -6.31% | -3.03% | -5.85% | -7.94% |
| Earnings before Tax (EBT) | - | 9.1 | 4.9 | -4.5 | - | - | - |
| Net income 1 | 6.1 | 4.3 | 2.8 | -7.2 | -4.4 | -5.684 | -9.587 |
| Net margin | - | 2.7% | 1.34% | -4.29% | -1.17% | -2.36% | -3.86% |
| EPS 2 | - | - | 0.0200 | -0.0600 | - | -0.0625 | -0.1429 |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 28/08/23 | 18/12/23 | 13/02/24 | 15/05/24 | 15/05/24 | - | - |
1EUR in Million2EUR
Estimates
Balance Sheet Analysis
| Fiscal Period: September | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - |
| Net Cash position 1 | - | 762 | 664 | 585 | 565 |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow 1 | - | -18 | -126 | -71.4 | 13.3 |
| ROE (net income / shareholders' equity) | - | 4.7% | -2.51% | 2.7% | 5.15% |
| ROA (Net income/ Total Assets) | - | 2.7% | -1.45% | 1.48% | 2.23% |
| Assets 1 | - | 833.3 | 2,229 | 1,644 | 2,153 |
| Book Value Per Share 2 | - | 5.900 | 5.670 | 5.730 | 6.070 |
| Cash Flow per Share 2 | - | -0.1300 | -0.5000 | -0.1400 | 0.5400 |
| Capex 1 | - | 3.8 | 51.1 | 69.6 | 71.4 |
| Capex / Sales | - | 0.58% | 5.62% | 6.18% | 5.22% |
| Announcement Date | 23/06/23 | 18/12/23 | - | - | - |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
11.54
EUR
Average target price
19.79
EUR
Spread / Average Target
+71.50%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -38.10% | 1.59B | |
| +12.82% | 10.91B | |
| +74.04% | 2.11B | |
| +36.83% | 2.08B | |
| -12.16% | 1.68B | |
| +16.40% | 1.06B | |
| -14.33% | 729M | |
| -25.12% | 698M | |
| +0.26% | 694M | |
| +18.18% | 501M |
- Stock Market
- Equities
- NCH2 Stock
- Financials thyssenkrupp nucera AG & Co. KGaA
